Stefan Agewall
#142,224
Most Influential Person Now
Stefan Agewall's AcademicInfluence.com Rankings
Stefan Agewallmedical Degrees
Medical
#2593
World Rank
#3023
Historical Rank
Cardiology
#239
World Rank
#245
Historical Rank
Stefan Agewallphilosophy Degrees
Philosophy
#7470
World Rank
#10690
Historical Rank
Logic
#4514
World Rank
#5823
Historical Rank
Download Badge
Medical Philosophy
Why Is Stefan Agewall Influential?
(Suggest an Edit or Addition)Stefan Agewall's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). (2018) (6316)
- 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. (2016) (4929)
- ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation (2012) (4622)
- [ESC/EAS Guidelines for the management of dyslipidaemias]. (2011) (3612)
- 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. (2020) (3083)
- ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). (2011) (3071)
- 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. (2016) (2451)
- [2016 European Guidelines on cardiovascular disease prevention in clinical practice]. (2016) (1881)
- 2015 ESC Guidelines for the diagnosis and management of pericardial diseases (2015) (1246)
- ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). (2011) (1103)
- 2018 ESC Guidelines for the diagnosis and management of syncope (2018) (942)
- 2016 European Guidelines on cardiovascular disease prevention in clinical practice (2012) (904)
- Editor's Choice - 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). (2018) (811)
- 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines (2016) (738)
- [2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.] (2018) (669)
- ESC working group position paper on myocardial infarction with non-obstructive coronary arteries. (2016) (603)
- 'Ten Commandments' from the 2016 ESC/EAS Guidelines for the management of dyslipidaemias. (2011) (596)
- Troponin elevation in coronary vs. non-coronary disease. (2011) (535)
- Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the Europe (2010) (520)
- Contemporary Diagnosis and Management of Patients With Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease: A Scientific Statement From the American Heart Association (2019) (410)
- Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia: A Systematic Review and Meta-analysis. (2015) (388)
- The importance of patient-reported outcomes: a call for their comprehensive integration in cardiovascular clinical trials. (2014) (268)
- Matrix metalloproteinases and cardiovascular disease. (2006) (255)
- Does a glass of red wine improve endothelial function? (2000) (220)
- Usefulness of microalbuminuria in predicting cardiovascular mortality in treated hypertensive men with and without diabetes mellitus. Risk Factor Intervention Study Group. (1997) (195)
- Endothelium-derived hyperpolarizing factor in vascular physiology and cardiovascular disease. (2009) (183)
- Matrix metalloproteinases in atherothrombosis. (2010) (179)
- Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy. (2013) (177)
- Gender differences in the effects of cardiovascular drugs (2017) (171)
- Chlamydia pneumoniae but not cytomegalovirus antibodies are associated with future risk of stroke and cardiovascular disease: a prospective study in middle-aged to elderly men with treated hypertension. (1999) (169)
- Myocardial infarction with normal coronary arteries is common and associated with normal findings on cardiovascular magnetic resonance imaging: results from the Stockholm Myocardial Infarction with Normal Coronaries study (2013) (131)
- Interrelation between the extent of atherosclerosis in the thoracic aorta, carotid intima-media thickness and the extent of coronary artery disease. (2005) (130)
- 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. (2017) (124)
- Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (2018) (123)
- Practical Instructions for the 2018 ESC Guidelines for the diagnosis and management of syncope (2018) (121)
- Remission is the goal for cardiovascular risk management in patients with rheumatoid arthritis: a cross-sectional comparative study (2011) (118)
- Troponin and exercise. (2016) (114)
- Carotid artery wall intima-media thickness is associated with insulin-mediated glucose disposal in men at high and low coronary risk. (1995) (113)
- Myocarditis or "true" infarction by cardiac magnetic resonance in patients with a clinical diagnosis of myocardial infarction without obstructive coronary disease: A meta-analysis of individual patient data. (2015) (110)
- Gender differences in the effect of cardiovascular drugs: a position document of the Working Group on Pharmacology and Drug Therapy of the ESC. (2015) (110)
- Ultrasound evaluation of atherosclerotic manifestations in the carotid artery in high-risk hypertensive patients. Risk Intervention Study (RIS) Group. (1994) (110)
- Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology (2018) (104)
- European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS) (2017) (103)
- The impact of renal dysfunction on outcomes in the ExTRACT-TIMI 25 trial. (2007) (100)
- Non‐invasive assessment of endothelial function – relation between vasodilatory responses in skin microcirculation and brachial artery (2004) (98)
- Myocardial infarction with angiographically normal coronary arteries. (2011) (98)
- Inflammatory markers and extent and progression of early atherosclerosis: Meta-analysis of individual-participant-data from 20 prospective studies of the PROG-IMT collaboration (2014) (87)
- Comparison of ultrasound assessment of flow-mediated dilatation in the radial and brachial artery with upper and forearm cuff positions. (2001) (84)
- Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk (2020) (81)
- Microalbuminuria in treated hypertensive men at high risk of coronary disease (1993) (79)
- Serum uric acid is associated with mortality and heart failure hospitalizations in patients with complicated myocardial infarction: findings from the High‐Risk Myocardial Infarction Database Initiative (2015) (76)
- COPD predicts mortality in HF: the Norwegian Heart Failure Registry. (2010) (75)
- Prevention of cardiovascular disease in rheumatoid arthritis. (2015) (73)
- Reduced quality of life after myocardial infarction in women compared with men (2004) (71)
- Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology. (2016) (70)
- Anti-CCP and RF IgM: predictors of impaired endothelial function in rheumatoid arthritis patients (2011) (69)
- Is thrombosis a contributor to heart failure pathophysiology? Possible mechanisms, therapeutic opportunities, and clinical investigation challenges. (2013) (67)
- European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS) (2017) (65)
- Microalbuminuria, insulin sensitivity and haemostatic factors in non‐diabetic treated hypertensive men (1995) (65)
- Multiple risk intervention trial in high risk hypertensive men: comparison of ultrasound intima‐media thickness and clinical outcome during 6 years of follow‐up (2001) (64)
- Urinary albumin excretion is associated with the intima‐media thickness of the carotid artery in hypertensive males with non‐insulin‐dependent diabetes mellitus (1995) (62)
- The Effects of Climate Change on Cardiac Health (2015) (59)
- Acute responses to phytoestrogens in small arteries from men with coronary heart disease. (2006) (57)
- Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management—a joint position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology (2015) (54)
- Chlamydia pneumoniae seropositivity is associated with carotid artery intima-media thickness. (2000) (52)
- Impaired endothelial function in persons with obstructive sleep apnoea: impact of obesity (2012) (52)
- Early Prediction of Increased Arterial Stiffness in Patients with Chronic Inflammation: A 15-year Followup Study of 108 Patients with Rheumatoid Arthritis (2011) (50)
- Effect of Angiotensin-converting enzyme inhibition on one-year mortality and frequency of repeat acute myocardial infarction in patients with acute myocardial infarction. (2010) (50)
- Methotrexate and anti-tumor necrosis factor treatment improves endothelial function in patients with inflammatory arthritis (2017) (48)
- Comprehensive efforts to increase adherence to statin therapy (2017) (47)
- Oral snuff impairs endothelial function in healthy snuff users (2004) (47)
- Evaluation of endothelial function using finger plethysmography (2009) (47)
- Prothrombin fragment 1+2 is a risk factor for myocardial infarction in treated hypertensive men (1998) (47)
- Risk Factors and Markers for Acute Myocardial Infarction With Angiographically Normal Coronary Arteries. (2015) (46)
- Adrenaline infusion in man increases muscle sympathetic nerve activity and noradrenaline overflow to plasma. (1989) (45)
- Does microalbuminuria predict cardiovascular events in nondiabetic men with treated hypertension? Risk Factor Intervention Study Group. (1995) (44)
- Femoral artery wall morphology, hemostatic factors and intermittent claudication: ultrasound study in men at high and low risk for atherosclerotic disease. (1996) (43)
- The efficacy of multiple risk factor intervention in treated hypertensive men during long‐term follow up (1994) (42)
- Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: a current opinion of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Council on Stroke. (2019) (41)
- Post‐occlusion brachial artery vasodilatation after ischaemic handgrip exercise is nitric oxide mediated (2002) (41)
- Serum levels of lipoprotein(a) and E-selectin are reduced in rheumatoid arthritis patients treated with methotrexate or methotrexate in combination with TNF-α-inhibitor. (2013) (40)
- Atherosclerotic disease in the femoral artery in hypertensive patients at high cardiovascular risk. The value of ultrasonographic assessment of intima-media thickness and plaque occurrence. Risk Intervention Study (RIS) Group. (1996) (40)
- Acute dilatation to phytoestrogens and estrogen receptor subtypes expression in small arteries from women with coronary heart disease. (2008) (39)
- Corrigendum to '2017 ESC/EACTS Guidelines for the management of valvular heart disease' [Eur J Cardiothorac Surg 2017;52:616-664]. (2017) (39)
- Negative feelings (discontent) predict progress of intima-media thickness of the common carotid artery in treated hypertensive men at high cardiovascular risk. (1996) (38)
- Reasons for disparity in statin adherence rates between clinical trials and real-world observations: a review (2018) (38)
- Risk Factors for Myocardial Infarction With Normal Coronary Arteries and Myocarditis Compared With Myocardial Infarction With Coronary Artery Stenosis (2012) (38)
- Mortality rates in treated hypertensive men with additional risk factors are high but can be reduced: a randomized intervention study. (1998) (37)
- Morphine in the treatment of acute pulmonary oedema--Why? (2016) (37)
- Morphological changes rather than flow-mediated dilatation in the brachial artery are better indicators of the extent and severity of coronary artery disease (2005) (36)
- The cost‐effectiveness of a cardiovascular multiple‐risk‐factor intervention programme in treated hypertensive men (1995) (36)
- Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology. (2016) (36)
- Is carbohydrate-deficient transferrin in serum useful for detecting excessive alcohol consumption in hypertensive patients? (1994) (36)
- Randomized evaluation of beta blocker and ACE-inhibitor/angiotensin receptor blocker treatment in patients with myocardial infarction with non-obstructive coronary arteries (MINOCA-BAT): Rationale and design. (2020) (35)
- Cardiac troponin I for prediction of clinical outcomes and cardiac function through 3-month follow-up after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. (2015) (34)
- Carotid artery wall morphology, haemostatic factors and cardiovascular disease. An ultrasound study in men at high and low risk for atherosclerotic disease (1994) (34)
- Microalbuminuria and intima-media thickness of the carotid artery in clinically healthy men. (2002) (33)
- Troponins in heart failure. (2015) (33)
- Effect of Myocardial Infarction With Nonobstructive Coronary Arteries on Physical Capacity and Quality-of-Life. (2017) (32)
- Carbohydrate-deficient transferrin is associated with insulin sensitivity in hypertensive men. (1994) (32)
- Is impaired flow-mediated dilatation of the brachial artery a cardiovascular risk factor? (2003) (32)
- Stroke was predicted by dimensions of quality of life in treated hypertensive men. (1998) (30)
- ESC guidelines adherence is associated with improved survival in patients from the Norwegian Heart Failure Registry. (2015) (30)
- Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure (2017) (29)
- Prevalence of Anxiety and Depression Symptoms in Patients with Myocardial Infarction with Non-Obstructive Coronary Arteries. (2018) (29)
- Atherosclerosis: Recent trials, new targets and future directions. (2015) (29)
- Multiple risk intervention in high-risk hypertensive patients. A 3-year ultrasound study of intima-media thickness and plaques in the carotid artery. Risk Intervention Study (RIS) Group. (1996) (29)
- Insulin Sensitivity and Hemostatic Factors in Clinically Healthy 58-year-old Men (2000) (28)
- Atorvastatin normalizes endothelial function in healthy smokers. (2006) (28)
- Endothelial function in conduit and resistance arteries in men with coronary disease. (2006) (27)
- European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS). (2017) (27)
- Early Comprehensive Cardiovascular Magnetic Resonance Imaging in Patients With Myocardial Infarction With Nonobstructive Coronary Arteries. (2021) (27)
- Prognostic value of combining high sensitive troponin T and N-terminal pro B-type natriuretic peptide in chest pain patients with no persistent ST-elevation. (2012) (26)
- Evaluation of point-of-care test systems using the new definition of myocardial infarction. (2003) (26)
- Gender differences among Norwegian patients with heart failure. (2011) (26)
- Independent relationship between microalbuminuria and plasminogen activator inhibitor-1 activity (PAI-1) activity in clinically healthy 58-year-old men. (2001) (24)
- Circulating levels of autoantibodies to oxidized low-density lipoprotein and C-reactive protein levels correlate with endothelial function in resistance arteries in men with coronary heart disease (2009) (23)
- Incremental value of a combination of cardiac troponin T, N-terminal pro-brain natriuretic peptide and C-reactive protein for prediction of mortality in end-stage renal disease (2011) (23)
- Insulin sensitivity and haemostatic factors in men at high and low cardiovascular risk (1999) (22)
- Antithrombotic Therapy and Major Adverse Limb Events in Patients With Chronic Lower Extremity Arterial Disease: Systematic Review and Meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaboration with the European Society of Cardiology Working (2019) (22)
- The value of a new cardiac magnetic resonance imaging protocol in Myocardial Infarction with Non-obstructive Coronary Arteries (MINOCA) – a case-control study using historical controls from a previous study with similar inclusion criteria (2017) (22)
- Troponin rise in healthy subjects during exercise test. (2011) (22)
- Anti-rheumatic treatment is not associated with reduction of pentraxin 3 in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis (2017) (21)
- Questions and Answers on Diagnosis and Management of Patients with Peripheral Arterial Diseases: A Companion Document of the 2017 ESC Guidelines for the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). (2017) (20)
- Handgrip exercise increases postocclusion hyperaemic brachial artery dilatation (1999) (20)
- Carvedilol Compared With Metoprolol Succinate in the Treatment and Prognosis of Patients With Stable Chronic Heart Failure: Carvedilol or Metoprolol Evaluation Study (2015) (20)
- Subclinical Atherosclerosis, Endothelial Function, and Serum Inflammatory Markers in Chronic Kidney Disease Stages 3 to 4 (2014) (20)
- Relationship between left ventricular ejection fraction and mortality after myocardial infarction complicated by heart failure or left ventricular dysfunction. (2018) (20)
- New-onset atrial fibrillation after recent coronary stenting: Warfarin or non-vitamin K-antagonist oral anticoagulants to be added to aspirin and clopidogrel? A viewpoint. (2015) (20)
- Adherence to guidelines and registry data. (2017) (20)
- New ESC/EACTS Guidelines for the management of atrial fibrillation. (2016) (19)
- Epidemiology and long-term outcome in outpatients with chronic heart failure in Northwestern Europe (2019) (18)
- Lipid management in rheumatoid arthritis: a position paper by the Cardiovascular Pharmacotherapy Working Group of European Society of Cardiology. (2020) (18)
- Diagnostic value of high sensitive troponin T in chest pain patients with no persistent ST-elevations (2011) (18)
- Impact of physical activity and body composition on heart function and morphology in middle‐aged, abdominally obese women (2010) (18)
- Comparative efficacy of sodium-glucose cotransporter-2 inhibitors (SGLT2i) for cardiovascular outcomes in type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials (2020) (17)
- Pharmacology of new treatments for hyperkalaemia: patiromer and sodium zirconium cyclosilicate (2019) (17)
- Intima–media complex of both the brachial artery and the common carotid artery are associated with left ventricular hypertrophy in patients with previous myocardial infarction (2005) (17)
- Non-insulin antidiabetic pharmacotherapy in patients with established cardiovascular disease: a position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy. (2018) (16)
- Should oral glucose tolerance test be a routine examination after a myocardial infarction? (2004) (16)
- Risk Factors That Predict Development of Microalbuminuria in Treated Hypertensive Men (1996) (16)
- Esomeprazole for Prevention and Resolution of Upper Gastrointestinal Symptoms in Patients Treated With Low-dose Acetylsalicylic Acid for Cardiovascular Protection: The OBERON Trial (2013) (16)
- Usefulness of troponin levels below the diagnostic cut-off level for acute myocardial infarction in predicting prognosis in unselected patients admitted to the coronary care unit. (2007) (15)
- Glucose intolerance is associated with C‐reactive protein and intima‐media anatomy of the common carotid artery in patients with coronary heart disease (2005) (15)
- Baseline low-density lipoprotein cholesterol to predict the extent of cardiovascular benefit from lipid-lowering therapies: a review (2018) (15)
- Non-alcoholic fatty liver disease and cardiovascular disease. (2012) (15)
- Expression of heat shock proteins and nitrotyrosine in small arteries from patients with coronary heart disease (2009) (15)
- Endothelial function improves within 6 weeks of treatment with methotrexate or methotrexate in combination with a TNF-α inhibitor in rheumatoid arthritis patients (2012) (15)
- 2-h postchallenge plasma glucose predicts cardiovascular events in patients with myocardial infarction without known diabetes mellitus (2012) (14)
- Microalbuminuria in patients with previous myocardial infarction. (2006) (14)
- Influence of receptor selectivity on benefits from SGLT2 inhibitors in patients with heart failure: a systematic review and head-to-head comparative efficacy network meta-analysis (2021) (14)
- Smoking and use of smokeless tobacco in treated hypertensive men at high coronary risk: utility of urinary cotinine determination (2002) (14)
- Acute and stable coronary heart disease: different risk factors. (2008) (14)
- Effect of tissue harmonic imaging and contrast upon between observer and test–retest reproducibility of left ventricular ejection fraction measurement in patients with heart failure (2004) (14)
- The burden of heart failure in the general population: a clearer and more concerning picture. (2018) (13)
- Increased Inflammatory Activity in Patients 3 Months after Myocardial Infarction with Nonobstructive Coronary Arteries. (2019) (13)
- Multifactorial treatment of hypertensive men at high cardiovascular risk and low‐density lipoprotein cholesterol affinity to human arterial proteoglycans (1996) (13)
- Medical Misinformation. (2019) (12)
- How should we evaluate an open artery in STEMI patients? (2005) (12)
- Echogenicity of the carotid intima–media complex and cardiovascular risk factors (2012) (12)
- Amyotrophic lateral sclerosis (ALS), a novel rare cause of elevated plasma troponin T levels. (2011) (12)
- ST-segment elevation and cardiac magnetic resonance imaging findings in myocardial infarction with non-obstructive coronary arteries. (2019) (12)
- Tumor necrosis factor inhibitors are associated with reduced complement activation in spondylarthropathies: An observational study (2019) (12)
- Relationship Between Oxidized LDL, IgM, and IgG Autoantibodies to ox-LDL Levels With Recurrent Cardiovascular Events in Swedish Patients With Previous Myocardial Infarction (2014) (11)
- 2016 ESC guidelines for the diagnosis and treatment of atrial fibrillation developed in collaboration with the EACTS (2017) (11)
- Lipoprotein(a) was an independent predictor for major coronary events in treated hypertensive men (2002) (11)
- “Troponin Elevation in Coronary Ischemia and Necrosis” (2014) (11)
- Personality Traits in Patients with Myocardial Infarction with Nonobstructive Coronary Arteries. (2019) (11)
- Morphine in acute heart failure. (2017) (11)
- Progression of conventional cardiovascular risk factors and vascular disease risk in individuals: insights from the PROG-IMT consortium (2019) (11)
- Comparative effectiveness of loop diuretics on mortality in the treatment of patients with chronic heart failure - A multicenter propensity score matched analysis. (2019) (10)
- Antithrombotic outcome trials in acute coronary syndromes: seeking the optimal balance between safety and efficacy. (2013) (10)
- Relations of Serum COMP to Cardiovascular Risk Factors and Endothelial Function in Patients with Rheumatoid Arthritis Treated with Methotrexate and TNF-α Inhibitors (2012) (10)
- Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week. (2022) (9)
- The new definition of myocardial infarction—Can we use it? (2005) (9)
- Treatment with β‐blockers—the value of an even plasma concentration over 24 h (1997) (9)
- Comparative effectiveness of enalapril, lisinopril, and ramipril in the treatment of patients with chronic heart failure: a propensity score-matched cohort study (2018) (9)
- Association between AMPD1 Gene Polymorphism and Coagulation Factors in Patients with Coronary Heart Disease (2006) (9)
- Association between spironolactone added to beta-blockers and ACE inhibition and survival in heart failure patients with reduced ejection fraction: a propensity score-matched cohort study (2013) (9)
- Prothrombin fragment 1 + 2 is associated with intima media thickness of the carotid artery in patients with myocardial infarction. (2009) (8)
- Potentially Inappropriate Prescriptions in Heart Failure with Reduced Ejection Fraction (PIP-HFrEF). (2020) (8)
- Mortality and adverse events with brand and generic clopidogrel in the Food and Drug Administration Adverse Event Reporting System (FAERS). (2018) (8)
- Oral antiplatelet agents in ACS: from pharmacology to clinical differences (2011) (8)
- Medical Misinformation: Vet the Message! (2019) (8)
- A randomized study of quality of life during multiple risk factor intervention in treated hypertensive men at high cardiovascular risk (1995) (8)
- Morphine in myocardial infarction: balancing on the tight rope. (2016) (8)
- Disturbed glucose metabolism is associated with left ventricular dysfunction using tissue Doppler imaging in patients with myocardial infarction (2007) (7)
- Clopidogrel inhibits platelet aggregation in patients on aspirin with stable chronic angina pectoris. (2008) (7)
- Increases of creatine kinase MB and cardiac troponin T in serum of a patient with uterine leiomyosarcoma. (2000) (7)
- The course of D-dimer, high-sensitivity C-reactive protein and pro-B-type natriuretic peptide in patients with non-ST-elevation myocardial infarction. (2011) (7)
- Ultrasound and radiology surrogate endpoints in pharmacological studies. (2012) (7)
- Effect of anti-rheumatic treatment on selenium levels in inflammatory arthritis. (2018) (7)
- Changes in diagnosing non-ST-segment elevation myocardial infarction after the introduction of a new high-sensitivity cardiac troponin T assay: a single-centre experience. (2012) (7)
- Some Aspects of Preventing Coronary Heart Disease (2012) (7)
- Antiplatelet treatment in acute coronary syndrome. Still an issue. (2019) (6)
- Cardiovascular pharmacotherapy. (2018) (6)
- Obstructive sleep apnea: no independent association to troponins (2014) (6)
- Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease. A review by the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy. (2022) (6)
- Impact of climate and air pollution on acute coronary syndromes: an update from the European Society of Cardiology Congress 2017 (2018) (6)
- Oral Anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1. (2019) (6)
- ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). (2011) (6)
- Potentially inappropriate prescriptions in heart failure with reduced ejection fraction: ESC position statement on heart failure with reduced ejection fraction-specific inappropriate prescribing (2020) (6)
- [Morphine in the treatment of acute pulmonary oedema]. (2014) (6)
- Neither endothelial function nor carotid artery intima-media thickness predicts coronary computed tomography angiography plaque burden in clinically healthy subjects: a cross-sectional study (2015) (5)
- Plasma catecholamine levels in the acute and subacute stages of takotsubo syndrome: Results from the Stockholm myocardial infarction with normal coronaries 2 study (2021) (5)
- New-onset atrial fibrillation after percutaneous coronary intervention with stent: Updated proposal of an algorithm for the choice of oral anticoagulant and its dose. (2017) (5)
- Cardiovascular pharmacotherapy and real-world data. (2018) (5)
- The european society of cardiology and the european atherosclerosis society (ESC/EAS) guidelines on the management of dyslipidemia (2011) (5)
- The Role of Pharmacogenomics in Contemporary Cardiovascular Therapy: A position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy. (2021) (5)
- Critical appraisal of the COMPASS trial. (2018) (5)
- Sunday, 26 August 2012 (2012) (5)
- All-Cause Mortality and Cardiovascular Outcomes With Non-Vitamin K Oral Anticoagulants Versus Warfarin in Patients With Heart Failure in the Food and Drug Administration Adverse Event Reporting System. (2019) (5)
- Low self-estimated quality of life after myocardial infarction and future cardiovascular risk. (2012) (5)
- The age of RCT`s 3 Important Aspects of RCT`s in Cardiovascular Pharmacotherapy with examples from Lipid and Diabetes Trials. (2019) (5)
- Minimizing bleeding events. (2020) (5)
- Should we do an oral glucose tolerance test in hypertensive men with normal fasting blood-glucose? (2001) (5)
- Update on management of hypokalemia and goals for the lower potassium level in patients with cardiovascular disease: A review in collaboration with the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy. (2021) (4)
- Coronary artery disease and arrhythmias. (2017) (4)
- Medical Misinformation: Vet the Message! (2019) (4)
- Patients' self-estimated likelihood of taking a statin as prescribed after different types of prognostic information. (2010) (4)
- Hyperkalemia and Renin–Angiotensin–Aldosterone System Inhibitors Dose Therapy in Heart Failure With Reduced Ejection Fraction (2019) (4)
- Antirheumatic treatment is associated with reduced serum Syndecan-1 in Rheumatoid Arthritis (2021) (4)
- Myeloid-related protein-8/14 and C-reactive protein in individuals evaluated for obstructive sleep apnea. (2014) (4)
- Heart rate prediction of outcome in heart failure following myocardial infarction depend on heart rhythm status an analysis from the high-risk myocardial infarction database initiative. (2017) (4)
- Unsolved issues in oral anticoagulation treatment in atrial fibrillation. (2019) (4)
- Plasma biomarker levels and non‐obstructive coronary artery disease determined by coronary computed tomography angiography (2018) (4)
- Physical exertion may cause high troponin levels. (2011) (4)
- Statins attenuate but do not eliminate the reverse epidemiology of total serum cholesterol in patients with non-ischemic chronic heart failure. (2017) (4)
- Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with RAAS-inhibitors-Coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology (2018) (3)
- The large clinical statin trials. (2011) (3)
- HIGH SENSITIVE TROPONIN T RULES OUT MYOCARDIAL INFARCTION 2 HOURS FROM ADMISSION IN CHEST PAIN PATIENTS. (2010) (3)
- Quality of life and insulin resistance in patients with coronary heart disease (2008) (3)
- Left ventricular ejection fraction and adjudicated, cause-specific hospitalizations after myocardial infarction complicated by heart failure or left ventricular dysfunction. (2019) (3)
- Sick leave and a smoking ban. (2014) (3)
- Racial and ethnic differences in pharmacotherapy to prevent coronary artery disease and thrombotic events (2022) (3)
- Impaired endothelial function in persons with obstructive sleep apnoea: impact of obesity—the response (2013) (3)
- End of story? Studies on prevention of reperfusion injury encounter perpetual defeats. (2015) (3)
- Insulin sensitivity and haemostatic factors in men at high and low cardiovascular risk. The Risk Factor Intervention Study Group. (1999) (3)
- Focus on subpopulations of atrial fibrillation patients. (2020) (3)
- Intima‐Media Thickness of Common Carotid and Brachial Arteries and Prothrombin Fragment 1 + 2 Are Associated with Left Ventricular Diastolic Dysfunction in Patients with Myocardial Infarction (2010) (3)
- Antirheumatic therapy is associated with reduced complement activation in rheumatoid arthritis (2022) (3)
- D9 - Urinary albumin excretion is associated with intima-media thickness of the carotid artery in hypertensive men with non-insulin-depenoent diabetes mellitus (1995) (2)
- Automatic identification of variables in epidemiological datasets using logic regression (2017) (2)
- Interpreting clinical trials: the ‘Beautiful’ case (2009) (2)
- Medical Misinformation: Vet the Message! (2019) (2)
- Can we offer tailor-made pharmacological treatment of patients with acute coronary syndrome? (2020) (2)
- AB0355 Anti-Rheumatic Therapy Reduces Syndecan-1 Shedding in Rheumatoid Arthritis (RA) (2015) (2)
- UEMS training requirements for angiology and vascular medicine: european standards of postgraduate medical specialist training (ETR Document). (2016) (2)
- Adherence to guidelines, compliance to treatment, and treatment quality. (2018) (2)
- Requirements for angiology/vascular medicine. (2013) (2)
- Medical misinformation: vet the message! (2019) (2)
- Anticoagulation, atherosclerosis, and heart failure. (2017) (2)
- Antirheumatic therapy is not associated with changes in circulating N-terminal pro-brain natriuretic peptide levels in patients with autoimmune arthritis (2021) (2)
- Reflexogenic neuronal and humoral responses to selective stimulation of low‐pressure cardiopulmonary receptors in man (1991) (2)
- MSc in Clinical Trials - A New Flagship Working Group Project. (2020) (2)
- Medical misinformation: Vet the message! (2019) (1)
- L30 Stroke is predicted by dimensions of quality of life in treated hypertensive men (1997) (1)
- Annual report of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy. (2016) (1)
- Levosimendan: perpetuum mobile? (2007) (1)
- The Prospective Studies of Atherosclerosis (Proof-ATHERO) Consortium: Design and Rationale (2020) (1)
- Antiplatelet treatment in coronary syndrome. (2021) (1)
- Clever idiot? (2003) (1)
- European Heart Journal - Cardiovascular Pharmacotherapy: A fast growing baby-filling an important gap in the literature. (2017) (1)
- Gender issues in cardiovascular medicine (2007) (1)
- The early diastolic myocardial velocity: a marker of increased risk in patients with coronary heart disease (2014) (1)
- The association of smoking to cardiovascular death differs according to age and sex following myocardial infarction complicated by heart failure or left ventricular dysfunction (2020) (1)
- Antiphospholipid antibodies in patients with myocardial infarction with and without obstructive coronary arteries (2021) (1)
- Old and new drugs in cardiovascular pharmacotherapy. (2019) (1)
- Challenges in Cardiovascular Pharmacogenomics Implementation: A viewpoint from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy. (2021) (1)
- Medical Misinformation. (2019) (1)
- EXCELLENT EARLY RISK STRATIFICATION USING TROPONINS AND N-TERMNIAL PRO-BRAIN NATRIURETIC PEPTIDES IN CHEST PAIN PATIENTS BUT NO ADDITIONAL VALUE OF HIGH-SENSITIVE TROPONIN T (2011) (1)
- Toward personalized medicine for cardiovascular pharmacotherapy. (2022) (1)
- New input on antiplatelet treatment and registry studies. (2018) (1)
- Fluoroquinolone use and valvular heart disease: is the jury still out? (2021) (1)
- Subgroup analyses in randomized clinical trials: Value and limitations Review #3 on important aspects of randomized clinical trials in cardiovascular pharmacotherapy. (2021) (1)
- Effects of Antirheumatic Treatment on Cell Cholesterol Efflux and Loading Capacity of Serum Lipoproteins in Spondylarthropathies (2022) (1)
- Treatment with beta-blockers--the value of an even plasma concentration over 24 h. (1997) (1)
- P4392Heart rate prediction of outcome in heart failure following myocardial infarction depend on heart rhythm status (2017) (1)
- Polypharmacy and adverse events in atrial fibrillation: Main cause or reflection of multimorbidity? (2022) (1)
- Atrial fibrillation in registries. (2020) (1)
- Focus on pharma in acute coronary syndrome. (2020) (1)
- 115 Adrenaline‐induced increases in plasma noradrenaline in man are due to an increased nerve activity rather than to prejunctional modulation of transmitter release (1988) (1)
- Cardiovascular pharmacotherapy. (2016) (0)
- Future of Antithrombotic Therapy for Heart Failure with Coronary Artery Disease. (2022) (0)
- SMALL-AREA ANALYSIS OF SHORT-TERM ASSOCIATIONTWEEN HEAT AND CARDIOVASCULAR MORTALITY IN FOUR EUROPEAN COUNTRIES (2023) (0)
- EHJ Cardiovascular Pharmacotherapy has Impact Factor. (2019) (0)
- The metabolic syndrome in hypertensive men: high risk of cardiovascular disease that may be reduced. (1999) (0)
- Can increased arterial stiffness in women relative to men be explained by their progressive loss of gluteofemoral fat? (2012) (0)
- Health-Related Quality-of-Life up to one year after myocardial infarction with non-obstructive coronary arteries. (2022) (0)
- Medical Misinformation. (2019) (0)
- [Final reply: follow the Danish example]. (2014) (0)
- [A healthy lifestyle in focus of new guidelines]. (2016) (0)
- Comprehensive Follow-Up Cardiac Magnetic Resonance of Patients With Myocardial Infarction With Nonobstructive Coronary Arteries. (2022) (0)
- Prevention is still the key to success. (2022) (0)
- [New guidelines for diagnosis and management of stable angina pectoris. Recommendations from the European Society of Cardiology]. (2014) (0)
- RESPONSE: Climate Change and Health: Challenges, Opportunities, and the Need for Action. (2023) (0)
- Future of European Heart Journal Cardiovascular Pharmacotherapy. (2022) (0)
- Medical Misinformation: Vet the Message! (2019) (0)
- AB0272 Anti-Rheumatic Treatment Is Not Associated with Reduction of Pentraxin 3 (PTX3) in Rheumatoid Arthritis (RA), Psoriatic Arthritis (PSA) and Ankylosing Spondylitis (AS) (2016) (0)
- News from EHJCVP. (2016) (0)
- We-P11:233 Influence of AMPD1 gene polymorphism on coagulation factors in patients with coronary heart disease (2006) (0)
- Letter to the Editor: Snus is not Harmless! (2003) (0)
- Ivabradine for heart failure: regulatory differences in Europe and United States. (2019) (0)
- [New European guidelines for acute myocardial infarction]. (2011) (0)
- The age of randomized clinical trials: three important aspects of randomized clinical trials in cardiovascular pharmacotherapy with examples from lipid, diabetes, and antithrombotic trials. (2020) (0)
- EARLY PREDICTORS OF CARDIOVASCULAR DISEASE (CVD) RISK: A 15-YEAR FOLLOW-UP STUDY OF 108 PATIENTS WITH RHEUMATOID ARTHRITIS (RA): PP.10.383 (2010) (0)
- Cardiovascular Pharmacotherapy is moving! (2015) (0)
- Hypertensive men at high cardiovascular risk : a study with focus on multifactorial risk factor intervention and pathophysiological and prognostic aspects of microalbuminuria (1994) (0)
- Optimizing individual heart failure treatment. (2022) (0)
- Different aspects of giving the optimal antiplatelet treatment. (2021) (0)
- Fibrates: One more lost paradise in lipid treatment. (2023) (0)
- Pharmacological treatment of CVD. (2022) (0)
- Subject Index Vol. 35, 2006 (2006) (0)
- Medical misinformation: vet the message! (2019) (0)
- Medical Misinformation. (2019) (0)
- The author’s reply. (2014) (0)
- [Why all these guidelines?]. (2014) (0)
- Adherence to pharmacological treatment: how can we improve? (2021) (0)
- Levels of NT-proBNP are associated with arterial stiffness in patients with Rheumatoid arthritis (2008) (0)
- Focus on different aspects of atrial fibrillation. (2022) (0)
- The application to MEDLINE from European Heart Journal-Cardiovascular Pharmacotherapy has been accepted! (2016) (0)
- [New European guidelines for acute and chronic heart failure]. (2013) (0)
- Early inflammation can predict arterial stiffness: a 15-year longitudinal study of 102 patients with Rheumatoid Arthtritis (2008) (0)
- Lipids and antithrombotic treatment. (2020) (0)
- [New guidelines for angina pectoris]. (2014) (0)
- Conventional treatment after myocardial infarction in routine clinical practice results in regression of left common carotid intima‐media thickness (2014) (0)
- Low general contentment is independently associated with progress of the intima-media thickness in the common carotid artery in treated hypertensive men. (1995) (0)
- Focus on blood pressure and risk factor intervention. (2020) (0)
- Stefan Agewall, Editor-in-Chief of new EHJ Cardiovascular Pharmacotherapy journal (2014) (0)
- high-risk hypertensive patients. Risk Intervention Study (RIS) Group Ultrasound evaluation of atherosclerotic manifestations in the carotid artery in (2011) (0)
- Myocardial infarction with normal coronary arteries is common and associated with normal findings on CMR - results from the Stockholm Myocardial Infarction with Normal Coronaries (SMINC) Study (2012) (0)
- Treating patients with anticoagulants and antiplatelet drugs is always a balance between risk for thrombosis vs. risk for bleeding. (2022) (0)
- Coronary Heart Disease Risk Factors Age Male gender Family history of CHD Smoking Unhealthy food choices Physical inactivity Psychosocial factors Abdominal obesity Hypertension Hypercholesterolemia Diabetes mellitus (2011) (0)
- AB0730 Cell cholesterol transport in spondyloarthritides and its response to anti-rheumatic drugs (2017) (0)
- Treatment with dual antiplatelet therapy after an acute coronary event may often be tailor-made for the patient. (2022) (0)
- A tailor-made suit always fits best. (2023) (0)
- [Re: Different guidelines for treatment of prostate cancer]. (2015) (0)
- Pathophysiology and Natural History (2008) (0)
- P2.06: LEVELS OF NT-PROBNP ARE ASSOCIATED WITH ARTERIAL STIFFNESS IN PATIENTS WITH RHEUMATOID ARTHRITIS (0)
- Medical Misinformation. (2019) (0)
- Update from EHJ CVP. (2016) (0)
- Sweet dreams might be bad. (2011) (0)
- [Bad taste in the mouth because of the article on snuff use]. (2004) (0)
- P6392Left ventricular ejection fraction and adjudicated, cause-specific hospitalizations after myocardial infarction complicated by heart failure or left ventricular dysfunction (2018) (0)
- European Heart Journal - Cardiovascular Pharmacotherapy has received its first Impact Factor of 6.723. (2019) (0)
- [New European guidelines for heart failure]. (2013) (0)
- European Heart Journal - Cardiovascular Pharmacotherapy: now accepted for an official Impact Factor. (2019) (0)
- [Troponin can be increased in healthy persons following moderate exercise]. (2012) (0)
- To treat or not to treat. (2022) (0)
- Thyroid Dysfunction in Patients With Myocardial Infarction With Normal Coronary Arteries (2013) (0)
- How to save six million people per year. (2015) (0)
- Cardiovascular magnetic resonance imaging commonly identifies a definitive diagnosis following normal echocardiography in myocardial infarction with nonobstructed coronary arteries (2022) (0)
- AB0343 ANTIRHEUMATIC THERAPY IS NOT ASSOCIATED WITH CHANGES IN CIRCULATING N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE (NT-PROBNP) LEVELS IN PATIENTS WITH RHEUMATOID ARTHRITIS (2019) (0)
- Metabolic control, anticoagulation, and gender aspects. (2017) (0)
- Medical Misinformation. (2019) (0)
- Never too late: a commentary on "Impact of age, sex and exercise on brachial and popliteal artery remodelling in humans". (2010) (0)
- Unsolved pharmacological issues with cardiology. (2021) (0)
- Association between spironolactone added to beta-blockers and ACE inhibition and survival in heart failure patients with reduced ejection fraction: a propensity score-matched cohort study (2013) (0)
- serum of rats after stressful, prolonged intense exercise Cardiac troponin T alterations in myocardium and (2015) (0)
- Does microalbuminuria predict cardiovascular mortality in treated hypertensive men (1996) (0)
- [Five different types of myocardial infarction defined by new guidelines]. (2008) (0)
- High-sensitivity cardiac troponin T is associated with disease activity in patients with inflammatory arthritis (2023) (0)
- Urinary albumin excretion and insulin metabolism in clinically healthy 58-year-old men. (2002) (0)
- Focus on lipid treatment. (2023) (0)
- The ArthritisInflammation: A 15-year Followup Study of 108 Patients with Rheumatoid Early Prediction of Increased Arterial Stiffness in Patients with Chronic (2011) (0)
- [Myocardial infarction with normal coronary arteries in women. MINCA--a specific type of myocardial infarction]. (2007) (0)
- Presence of eNOS TT genotype is associated with a poor prognosis in patients with a previous myocardial infarction (2013) (0)
- European Heart Journal - CVP: what is next? (2015) (0)
- Abstract 3297: The Impact of Renal Dysfunction on Bleeding and Outcome in ST-Elevation MI: Results of the ExTRACT-TIMI25 Study (2006) (0)
- P1814Deaths and vascular outcomes with non-vitamin K oral anticoagulants versus warfarin in patients with heart failure in the food and drug administration adverse event reporting system (2018) (0)
- [Wanted: Politics against heart attacks]. (2013) (0)
- Contents Vol. 131, 2015 (2015) (0)
- SAT0108 Methotrexate and Anti-TNF Treatment Improve Endothelial Function in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis (2016) (0)
- [New European guidelines for myocardial infarction without ST-segment elevation. Quicker diagnosis saves money--demands for angiography also during weekends costs more]. (2011) (0)
- Second year of a journal. (2016) (0)
- Medical misinformation: vet the message! (2019) (0)
- European Heart Journal - Cardiovascular Pharmacotherapy: a new journal within the European Heart Journal family. (2015) (0)
- individual-participant-data from 20 prospective studies of the PROG-IMT collaboration Inflammatory markers and extent and progression of early atherosclerosis : Meta-analysis of (2014) (0)
- Starting up a new Journal within the European Heart Journal Family. (2015) (0)
- GuidelinesESC/EAS Guidelines for the Management of Dyslipidaemias (2013) (0)
- The association between apnoea-hypopnoea index and flow-mediated dilation of brachial artery (2013) (0)
- Tu-P9:363 Atorvastatin normalizes endothelial function in healthy smokers (2006) (0)
- Wednesday, 29 August 2012 (2012) (0)
- Ivabradine: an hypothesis generating study--an important link between bench and bedside. (2011) (0)
- Medical Misinformation. (2019) (0)
- Early arterial abnormalities in young adulthood. (2012) (0)
- Focus on optimizing treatment of coronary heart disease. (2022) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Stefan Agewall?
Stefan Agewall is affiliated with the following schools:
